Engineering PapersSearch

Engineering topics

Lang, T.

Publications and source records attributed to Lang, T..

It's Time for Color Vision Deficiency Friendly Color Maps in the Radar Community

Color Vision Deficiency (CVD) is a decreased ability to discern between particular colors. 8% of men and 0.4% of women have some form of CVD. An informal poll of AGU and AMS twitter followers yielded 10% of 70 respondents self identifying as having CVD. When presenting data on a two-dimensional plane it is common to use colors to represent values, the mapping between values and colors is known as a colormap. Colormap choice is personal and is influenced by: (1) Ability to highlight scientifically interesting data. (2) Institutional choices (supervisor insists on a certain colormap). (3) Domain dominance of a particular colormap (common in the radar community). Colormap choice should be influenced by: (1) Ability to highlight scientifically interesting data. (2) Perceptual uniformity (thus not creating artificial structure). (3) Approachability by those with visual impairments (CVD). (4) Ideally, but not always achievable, reproducibility in greyscale.

Colormap

Evaluation of Multiple Doppler Retrievals of Convection in Darwin

Climate Model Development and Validation: (1) DOE's E3SM model being developed with goal of an increased resolution of 13 km (right arrow) assumptions made in convective parameterizations may not apply. (2) Need long term dataset with quantifiable large scale forcings to evaluate performance of convective parameterizations. (3) Vertical velocities are critical for calculating mass fluxes but are poorly represented in GCMs. (4) Dual Doppler techniques can retrieve vertical velocities, but uncertainties can be high due to sampling, mass continuity assumptions, fall speed assumptions, boundary conditions. (5) Can use high-resolution model simulated radar variables to assess impacts of such uncertainties

Doppler

Update of Bisphosphonate Flight Experiment

Elevated bone resorption is a hallmark of human spaceflight and bed rest indicating that elevated remodeling is a major factor in the etiology of space flight bone loss. In a collaborative effort between the NASA and JAXA space agencies, we are testing whether an antiresorptive drug would provide additional benefit to in-flight exercise to ameliorate bone loss and hypercalciuria during long-duration spaceflight. Measurements of bone loss include DXA, QCT, pQCT, urinary and blood biomarkers. We have completed analysis of R+1year data from 7 crewmembers treated with alendronate during flight, as well as immediate post flight (R+<2wks) data from 6 of 10 concurrent controls without treatment. The treated astronauts used the Advanced Resistive Exercise Device (ARED) during their missions. The purpose of this report is twofold: 1) to report the results of inflight, post flight and one year post flight bone measures compared with available controls with and without the use of ARED; and 2) to discuss preliminary data on concurrent controls. The figure below compares the BMD changes in ISS crewmembers exercising with and without the current ARED protocol and the alendronate treated crewmembers also using the ARED. This shows that the use of ARED prevents about half the bone loss seen in early ISS crewmembers and that the addition of an antiresorptive provides additional benefit. Resorption markers and urinary Ca excretion are not impacted by exercise alone but are significantly reduced with antiresorptive treatment. Bone measures for treated subjects, 1 year after return from space remain at or near baseline. DXA data for the 6 concurrent controls using the ARED device are similar to DXA data shown in the figure below. QCT data for these six indicate that the integral data are consistent with the DXA data, i.e., comparing the two control groups suggests significant but incomplete improvement in maintaining BMD using the ARED protocol. Biochemical data of the concurrent control group await sample return and analysis. The preliminary conclusion is that an antiresorptive may be an effective adjunct to exercise during long-duration spaceflight.

LeBlanc, A.

Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss

This poster reviews the possibility of using Bisphosphonates to counter the bone loss that is experienced during space flight. The Hypothesis that is tested in this experiment is that the combined effect of anti-resorptive drugs plus in-flight exercise regimen will attenuate space flight induced loss in bone mass and strength and reduce renal stone risk. The experiment design, the status and the results are described.

LeBlanc, A.

Development of an Integrated Countermeasure Device for Long Duration Space Flight and Exploration Missions

Musculoskeletal, cardiovascular, and sensorimotor deconditioning have been observed consistently in astronauts and cosmonauts following long-duration spaceflight. Studies in bed rest, a spaceflight analog, have shown that high intensity resistive or aerobic exercise attenuates or prevents musculoskeletal and cardiovascular deconditioning, respectively, but complete protection has not been achieved during spaceflight. Exercise countermeasure hardware used during earlier International Space Station (ISS) missions included a cycle ergometer, a treadmill, and the interim resistive exercise device (iRED). Effectiveness of the countermeasures may have been diminished by limited loading characteristics of the iRED as well as speed restrictions and subject harness discomfort during treadmill exercise. The Advanced Resistive Exercise Device (ARED) and the second generation treadmill were designed to address many of the limitations of their predecessors, and anecdotal reports from ISS crews suggest that their conditioning is better preserved since the new hardware was delivered in 2009. However, several countermeasure devices to protect different physiologic systems will not be practical during exploration missions when the available volume and mass will be severely restricted. The combined countermeasure device (CCD) integrates a suite of hardware into one device intended to prevent spaceflight-induced musculoskeletal, cardiovascular, and sensorimotor deconditioning. The CCD includes pneumatic loading devices with attached cables for resistive exercise, a cycle for aerobic exercise, and a 6 degree of freedom motion platform for balance training. In a proof of concept test, ambulatory untrained subjects increased muscle strength (58%) as well as aerobic capacity (26%) after 12-weeks of exercise training with the CCD (without balance training), improvements comparable to those observed with traditional exercise training. These preliminary results suggest that this CCD can concurrently improve musculoskeletal and cardiovascular conditioning in ambulatory subjects, but further work is required to validate its use as countermeasure to spaceflight-induced deconditioning.

Lee, S. M. C.

Bisphosphonate as a Countermeasure to Space Flight-Induced Bone Loss

The purpose of this research is to determine whether anti-resorptive pharmaceuticals such as bisphosphonates, in conjunction with the routine in-flight exercise program, will protect ISS crewmembers from the regional decreases in bone mineral density and bone strength and the increased renal stone risk documented on previous long-duration space flights [1-3]. Losses averaged ~ 1 to 2 percent per month in such regions as the lumbar spine and hip. Although losses showed significant heterogeneity among individuals and between bones within a given subject, space flight-induced bone loss was a consistent finding. More than 90 percent of astronauts and cosmonauts on long-duration flights (average 171 days) aboard Mir and the ISS, had a minimum 5 percent loss in at least one skeletal site, 40 percent of them had a 10 percent or greater loss in at least one skeletal site, and 22 percent of the Mir cosmonauts experienced a 15 to 20 percent loss in at least one site. These losses occurred even though the crewmembers performed time-consuming in-flight exercise regimens. Moreover, a recent study of 16 ISS astronauts using quantitative computed tomography (QCT) demonstrated trabecular bone losses from the hip averaging 2.3 percent per month [4]. These losses were accompanied by significant losses in hip bone strength that may not be recovered quickly [5]. This rapid loss of bone mass results from a combination of increased and uncoupled remodeling, as demonstrated by increased resorption with little or no change in bone formation markers [6-7]. This elevated remodeling rate likely affects the cortical and trabecular architecture and may lead to irreversible changes. In addition to bone loss, the resulting hypercalciuria increases renal stone risk. Therefore, it is logical to attempt to attenuate this increased remodeling with anti-resorption drugs such as bisphosphonates. Success with alendronate was demonstrated in a bed rest study [8]. This work has been extended to space flight and two dosing regimens: 1) an oral dose of 70 mg of alendronate taken weekly during flight or 2) a single intravenous (IV) dose of 4 mg of zoledronic acid given several weeks before flight. Currently the study is focusing on the oral option because of NASA s safety concerns with the IV-administered drug. The protocol requests 10 male or female crewmembers on ISS flights of 90 days or longer. Controls are 16 previous ISS crewmembers with QCT scans of the hip performed by these same investigators. The primary outcome measure for this study is hip trabecular bone mineral density measured by QCT, but other measures of bone mass are performed including peripheral QCT (pQCT) and dual-energy x-ray absorptiometry. Serum and urinary bone markers and renal stone risk measured before, during, and after flight are included. Postflight data are currently being collected from 2 ISS crewmembers. Two additional crewmembers will return this spring after ~6-month missions. To date no untoward effects have been encountered.

Spector, Elisabeth

Low Magnitude Mechanical Signals Reduce Risk-Factors for Fracture during 90-Day Bed Rest

Long duration spaceflight leads to multiple deleterious changes to the musculoskeletal system, where loss of bone density, an order of magnitude more severe than that which follows the menopause, combined with increased instability, conspire to elevate the risk of bone fracture due to falls on return to gravitational fields. Here, a ground-based analog for spaceflight is used to evaluate the efficacy of a low-magnitude mechanical intervention, VIBE (Vibrational Inhibition of Bone Erosion), as a potential countermeasure to preserve musculoskeletal integrity in the face of disuse. Twenty-six subjects consented to ninety days of six-degree head-down tilt bed-rest. 18 completed the 90d protocol, 8 of which received daily 10-minute exposure to 30 Hz, 0.3g VIBE, applied in the supine position using a vest elastically coupled to the vibrating platform. The shoulder harness induced a load of 60% of the subjects body weight. At baseline and 90d, Qualitative Ultrasound Scans (QUS) of the calcaneus and CT-scans of the hip and spine were performed to measure changes in bone density. Postural control (PC) was assessed through center of pressure (COP) recordings while subjects stood on a force platform for 4 minutes of quiet stance with eyes closed, and again with eyes opened. As compared to control bedrest subjects,

Muir, J. W.

General approaches for achieving high speed computations

The basic organizational approach to achieve high speed computations has been to execute several instructions concurrently. Various algorithmic structures and related computer organizations have been identified and used for this purpose. Each of them is better suited for some classes of applications, provides a potential speed-up with respect to the sequential computer, and suffers from degradation factors that reduce the effective speed-up obtained. The basic algorithmic structures are presented, the corresponding computer organizations described and the potential degradation factors identified. Also included are considerations related to the cost of the system and to the corresponding programming methodology.

Lang, T.

Functional language and data flow architectures

This is a tutorial article about language and architecture approaches for highly concurrent computer systems based on the functional style of programming. The discussion concentrates on the basic aspects of functional languages, and sequencing models such as data-flow, demand-driven and reduction which are essential at the machine organization level. Several examples of highly concurrent machines are described.

Ercegovac, M. D.

Transducer technology transfer to bio-engineering applications

The results of a technology transfer of a miniature unidirectional stress transducer, developed for experimental stress analysis in the aerospace field, to applications in bioengineering are reported. By modification of the basic design and innovations in attachment techniques, the transducer was successfully used in vivo on the myocardium of large dogs to record the change in contractile force due to coronary occlusion, reperfusion, and intervention.

Duran, E. N.

Computer analysis of large structural systems.

Numerical procedure for structural systems analysis, discussing computer application to hydrodynamic, electric, magnetic, thermodynamic, elastostatic and elastodynamic problems

Bamford, R.

Computer analysis of large structural systems.

Numerical procedure for structural systems analysis, discussing computer application to hydrodynamic, electric, magnetic, thermodynamic, elastostatic and elastodynamic problems

NUMERICAL ANALYSIS